ギラン・バレ症候群
Hugh J Willison1, Bart C Jacobs2, Pieter A van Doorn3
1Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, UK.
Lancet (London, England)
|March 8, 2016
まとめ
ギラン・バレー症候群は 重度の麻痺性神経疾患で 毎年10万人に罹患しています トリガーとメカニズムの理解における進歩は この急性自己免疫神経疾患の 新しい治療法とバイオマーカーを導き出しています
科学分野:
- 神経学
- 免疫学
- 病理学について
背景:
- ギラン・バレー症候群は急性麻痺神経症の重要な原因で,年間約10万例の発生率があります.
- 患者の20〜30%で呼吸不全を呈する重症な形態を含む.
- 現在の最適な治療は,静脈内免疫グロブリンまたはプラズマ交換で,サポートケアで補完されます.
研究 の 目的:
- グイラン・バレー症候群の現在の理解,その変種と管理を要約します.
- 感染症の誘発因子,免疫的,病理的メカニズムの理解における最近の進歩を強調する.
- 結果予測やバイオマーカーの開発における継続的な共同研究の重要性を強調する.
主な方法:
- ギラン・バレ症候群に関する最新文献のレビュー
- 世界規模の共同研究から得られたデータの分析
- 病気のメカニズムと治療の有効性の理解における進歩に焦点を当てます.
主要な成果:
- グイラン・バリ症候群の感染誘発因子と免疫学的根拠を理解する上で 重要な進歩です
- 静脈内免疫グロブリンとプラズマ交換を最適な治療法として特定する.
- 結果予測やバイオマーカーのデータを収集するための大規模な研究を開始する.
結論:
- グイラン・バリ症候群のメカニズムの理解は 大きく進歩しました
- 改善された科学的洞察に基づいて新しい治療法が調査されています.
- 共同研究は より良い診断ツールを開発し 急性自己免疫性神経疾患の 結果を予測するのに不可欠です
さらに関連する動画
09:29Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
Published on: August 21, 2017
12.1K
08:16Utility of Dissociated Intrinsic Hand Muscle Atrophy in the Diagnosis of Amyotrophic Lateral Sclerosis
Published on: March 4, 2014
33.6K
関連する概念動画
Myasthenia Gravis: Overview and Treatment
3.4K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.4K
Myasthenia Gravis: Diagnostic Tests
3.1K
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
3.1K
Disorders of the Skeletal Muscle
2.3K
The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
2.3K
Chemical Synapses
12.4K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
12.4K
Chemical Synapses
8.1K
Chemical synapses are specialized sites between two neurons or between a neuron and a non-neuronal cell like a muscle, glandular or sensory cell.
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
Because chemical synapses depend on the release of neurotransmitter molecules from synaptic vesicles to pass on their signal, there is an approximately one millisecond delay between when the axon potential reaches the presynaptic terminal and when the neurotransmitter leads to opening of postsynaptic ion channels. Additionally, this signaling is...
8.1K
